These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 305876)

  • 21. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D; Byham-Gray L; Lewis E; McCaffrey S
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium and phosphorus metabolism in maintenance hemodialysis.
    Ritz E; Mehls O; Krempien B
    Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
    [No Abstract]   [Full Text] [Related]  

  • 23. Low levels of serum calcium, phosphorus and plasma 25-hydroxy vitamin D in cirrhosis of the liver.
    Meyer MS; Wexler S; Jedvab M; Spirer Z; Keysar N; Shibolet S
    Isr J Med Sci; 1978 Jul; 14(7):725-30. PubMed ID: 681162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [25-hydroxy vitamin D deficiency with reduction of intestinal calcium absorption and bone density in chronic alcoholism].
    Luisier M; Vodoz JF; Donath A; Courvoisier B; Garcia B
    Schweiz Med Wochenschr; 1977 Oct; 107(43):1529-33. PubMed ID: 929127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
    Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic alcoholic liver disease. Ionized blood calcium measurements in 24 patients (author's transl)].
    Louboutin JY; Feuillu A; Bansard JY; Brissot P; Pawlotsky Y; Bourel M
    Nouv Presse Med; 1980 May; 9(24):1689-90. PubMed ID: 7465398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D prophylaxis in children with a single dose of 150000 IU of vitamin D.
    Oliveri B; Cassinelli H; Mautalen C; Ayala M
    Eur J Clin Nutr; 1996 Dec; 50(12):807-10. PubMed ID: 8968701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redefining vitamin D insufficiency.
    Malabanan A; Veronikis IE; Holick MF
    Lancet; 1998 Mar; 351(9105):805-6. PubMed ID: 9519960
    [No Abstract]   [Full Text] [Related]  

  • 30. [Calcium-phosphate metabolism in chronic polyarthritis].
    Siegmeth W; Dudczak R; Zazgornik J
    Z Rheumatol; 1982; 41(1):16-8. PubMed ID: 7080689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parathyroid hormone, calcitonin, 25-hydroxycholecalciferol and the morphological status of the bones in rheumatoid arthritis].
    Kokot F; Kuska J; Białas B; Gburek Z; Szczurek Z; Sledziński Z; Luciak M
    Reumatologia; 1980; 18(4):353-60. PubMed ID: 7244437
    [No Abstract]   [Full Text] [Related]  

  • 32. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
    Lindberg J; Martin KJ; González EA; Acchiardo SR; Valdin JR; Soltanek C
    Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum vitamin D metabolites and bone mineralization in young children with chronic low to moderate lead exposure.
    Koo WW; Succop PA; Bornschein RL; Krug-Wispe SK; Steinchen JJ; Tsang RC; Berger OG
    Pediatrics; 1991 May; 87(5):680-7. PubMed ID: 2020514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone changes in alcoholic liver cirrhosis. A histomorphometrical analysis of 52 cases.
    Jorge-Hernandez JA; Gonzalez-Reimers CE; Torres-Ramirez A; Santolaria-Fernandez F; Gonzalez-Garcia C; Batista-Lopez JN; Pestana-Pestana M; Hernandez-Nieto L
    Dig Dis Sci; 1988 Sep; 33(9):1089-95. PubMed ID: 3044713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parathyroid glands and bone calcium mobilization by 25-hydroxycholecalciferol.
    Cuisinier-Gleizes P; Delorme A; Dulac H; Mathieu H
    Rev Eur Etud Clin Biol; 1972 Nov; 17(9):903-5. PubMed ID: 4653993
    [No Abstract]   [Full Text] [Related]  

  • 36. A confusion of vitamin D's.
    Raisz LG
    N Engl J Med; 1972 Nov; 287(18):926-7. PubMed ID: 4342434
    [No Abstract]   [Full Text] [Related]  

  • 37. Defective vitamin D metabolism in thalassemia major.
    Zaino EC; Yeh JK; Aloia J
    Ann N Y Acad Sci; 1985; 445():127-34. PubMed ID: 3874574
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of osteoporosis with vitamin D.
    Buring K; Hulth AG; Nilsson BE; Westlin NE; Wiklund PE
    Acta Med Scand; 1974 Jun; 195(6):471-2. PubMed ID: 4546154
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the effects of crystalline dihydrotachysterol, vitamin D2 and parathyroid extract on calcium and phosphorus metabolism in man.
    TEREPKA AR; CHEN PS
    J Clin Endocrinol Metab; 1962 Oct; 22():1007-17. PubMed ID: 13980645
    [No Abstract]   [Full Text] [Related]  

  • 40. Low serum 25-hydroxy-calciferols and intact hepatic 25-hydroxylation in patients with decompensated post-necrotic hepatic cirrhosis.
    Tsai KS; Chang CC; Yang PM; Chen FW
    Taiwan Yi Xue Hui Za Zhi; 1987 Jan; 86(1):33-8. PubMed ID: 3494810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.